Navigation Links
BiOptix to highlight new carbonic anhydrase data at IBC's Biopharmaceutical Development & Production Week

BOULDER, Colo. and HUNTINGTON BEACH, Calif., Feb. 27, 2013 /PRNewswire/ -- BiOptix is highlighting new and compelling small molecule kinetics data from the new BiOptix 404pi at the IBC Biopharmaceutical Development & Production Week to be held from February 25 – March 1 2013 in Huntington Beach, CA.  These new data sets continue to underscore the versatility of the BiOptix 404pi, an SPR instrument that is built for both protein-protein kinetics as well as protein-small molecule interactions.

"The carbonic anhydrase data from the BiOptix 404pi demonstrate the cornerstone of the BiOptix value proposition:  high sensitivity, low noise and an ability to evaluate small molecule models," noted Ken Wilczek , Vice President of Sales and Marketing for BiOptix.  "Carbonic anhydrase analysis is the gold standard for evaluating SPR instrumentation and the BiOptix 404pi produces excellent data.  BiOptix has designed and built—in the USA—a versatile SPR instrument that is available to the research community at a reasonable price."

Researchers are invited to learn more about the new BiOptix 404pi via the BiOptix Innovators Program—a unique to the industry "try before you buy" SPR instrumentation demo program.  Additional details can be found at:

Surface Plasmon Resonance is an advanced and highly sensitive optical technology that measures refractive index changes on a sensor chip's gold surface due to a change in mass that occurs during a binding event. This change can be used to monitor biological interactions such as the concentration of target molecules, kinetic rates and affinity constants. BiOptix has developed and patented a novel ultra-sensitive detection platform known as Enhanced Surface Plasmon resonance, or ESPR. Unlike traditional SPR, ESPR instrumentation from BiOptix enables the high sensitivity of SPR with the high stability and lower noise of common path interferometry.

About BiOptix

BiOptix Diagnostics Corporation is a privately held firm based in Boulder, Colorado, with leading investments from Boulder Ventures and Rusnano.  BiOptix has developed a new class of analytical biosensor instrumentation utilizing a patented high-throughput label-free technology known as ESPR – Enhanced Surface Plasmon Resonance. BiOptix instrumentation allows researchers to study label-free protein-protein and protein-small molecule interaction—with high sensitivity and high throughput. Applications include: Protein-small molecule interactions, protein-protein kinetics, antibody affinities and epitope mapping, oligosaccharide characterization, nucleic acid (DNA-DNA or DNA-RNA) hybridization and biomolecule concentration measurements. Additional information about BiOptix and our products can be found at:

SOURCE BiOptix Diagnostics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. BiOptix Announces Fall 2012 Tradeshow and Symposia Schedule
2. BiOptix announces expansion of Innovators Program at Molecular Med TRI-CON 2013
3. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
4. Staffing and Performance Benchmarks for Quality Function Highlight New Medical Device Study
5. Isis Reports Financial Results and Highlights for First Quarter 2012
6. Delcath Highlights First Quarter 2012 And Recent Accomplishments
7. Soligenix Reports First Quarter 2012 Financial Results and Highlights Recent Accomplishments
8. Volcano to Highlight its Leadership in Precision Guided Therapy at EuroPCR 2012
9. "Emergency Medical Services Week" Highlights Stroke Survivors and Awareness
10. PharMEDium Highlights Enhanced Labeling for ICU Services at Critical Care Expo
11. MedVantx MedStart™ Solves Problem Highlighted in Study Published in Journal of the American Board of Family Medicine - Expired Medications in Physician Office Sample Closets
Post Your Comments:
(Date:6/24/2016)... -- The Academy of Managed Care Pharmacy (AMCP) today ... allow biopharmaceutical companies to more easily share health care ... coverage decisions, a move that addresses the growing need ... The recommendations address restrictions in the sharing of product ... a prohibition that hinders decision makers from accessing HCEI ...
(Date:6/24/2016)... Research and Markets has announced the addition of the ... to their offering. ... World Market for Companion Diagnostics covers the world market for ... report includes the following: , World IVD ... (N. America, EU, ROW), 2015-2020 , World IVD Companion ...
(Date:6/24/2016)... Belgium , June 24, 2016 ... the appointment of Dr. Edward Futcher ... Non-Executive Director, effective June 23, 2016.Dr. Futcher was ... Nominations and Governance Committees.  As a non-executive member ... independent expertise and strategic counsel to VolitionRx in ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. ... the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has ... , Sickle Cell Disease (SCD) is a disorder of the red blood cells, which ...
(Date:6/24/2016)... ... , ... Global law firm Greenberg Traurig, P.A. announced that 20 Florida attorneys ... peers for this recognition are considered among the top 2 percent of lawyers practicing ... members of this year’s Legal Elite Hall of Fame: Miami Shareholders Mark D. ...
(Date:6/24/2016)... ... ... of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum Wage’ ... 2020 and then adjusting it yearly to increase at the same rate as the median ... floor does not erode again, and make future increases more predictable. , The company is ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Haute Beauty Network, ... M. Weintraub as a prominent plastic surgeon and the network’s newest partner. ... the most handsome men, look naturally attractive. Plastic surgery should be invisible.” He ...
(Date:6/24/2016)... ... 24, 2016 , ... National recruitment firm Slone Partners is pleased ... and genomics experience, as Vice President of North American Capital Sales at HTG ... leading the sales team in the commercialization of the HTG EdgeSeq system and associated ...
Breaking Medicine News(10 mins):